# PrideRx reviews (2026): GLP-1 telehealth sellers | This GLP Three approved products routed through the manufacturers' own channels, each with a required monthly membership beside it. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/priderx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Brand drugs, plus a membership # PrideRx review Three approved products routed through the manufacturers' own channels, each with a required monthly membership beside it. ## The verdict PrideRx routes FDA-approved products through LillyDirect and NovoCare, at $149 to $299 in medication, plus a required $99 monthly membership. The all-in figures are $248 for the orals and $398 for the Zepbound pen. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Orforglipron · Semaglutide · Tirzepatide Form Injection · Oral Injection From $398/mo Oral From $248/mo Prescription Required Compounded No PrideRx arranges access to brand orforglipron, brand oral semaglutide and the brand tirzepatide pen, rather than dispensing compounded preparations of its own. 1. ## Who writes the prescription, and what do they see? The membership is what the clinical relationship costs here, and it is stated: $25 for a first month and $99 a month after. What it buys is not described in the same detail as what it costs. This is a different business from most sellers a reader will meet. The medication comes from the manufacturer's channel at the manufacturer's price, and PrideRx charges for the access and the prescribing around it. That is a clearer separation than a bundled figure, and it means the two charges have to be added. 2. ## What happens when the dose goes up? All three lines are dose-tiered by the manufacturer and the pages say so. Foundayo runs from $149 at the starter dose to $299 at higher ones, and the Zepbound pen from $299 at 2.5 mg to $449 at 7.5 mg and above. A reader escalating pays the manufacturer's ladder plus the same membership throughout. 3. ## What the price includes At the entry doses the all-in figures are $248 a month for either oral and $398 for the Zepbound pen. At the top of the published ladders they become $398 and $548. Six months at the oral entry rate is $1,488 counting the $25 first month. Budgeting from the medication figure alone understates every one of these by $99 a month. 4. ## What it claims, and what it cites Foundayo, the [Wegovy](https://thisglp.com/research/semaglutide-cochrane-review) Pill and the [Zepbound](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) KwikPen are FDA-approved brand products dispensed through the manufacturers' own channels. Nothing here is compounded, so the caution about an unreviewed preparation does not apply. ## Where it holds up, and where it does not - Strength: FDA-approved products throughout - Strength: Manufacturer channels named explicitly - Strength: Dose ladders published on all three lines - Strength: The membership is disclosed in writing - Limitation: A $99 monthly membership is required - Limitation: The medication figure excludes it - Limitation: Top doses reach $449 before membership - Limitation: No state coverage list is recorded ## What the evidence says about this kind of treatment The assessment above is about PrideRx. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants an approved product and has added the membership to the ladder. Wrong for A reader comparing the medication figure against a compounded all-in price. ## The evidence behind what PrideRx prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide](https://thisglp.com/research/what-is-orforglipron) A small-molecule daily tablet, not a peptide. Over 72 weeks in 3,127 adults, weight fell 11.2% on the top dose against 2.1% on placebo. No trial has compared it against an injection. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How PrideRx compares | Seller | Who it suits | Go | | --- | --- | --- | | NovoCare Pharmacy | Readers who want the approved product and will count thirteen boxes a year rather than twelve | | | PeterMD | Readers who want a cancel-anytime subscription and will choose the monthly product over the quarterly offer | | | Options Medical Weight Loss | Readers certain of a year who can pay the whole of it at once | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [altRX](https://thisglp.com/reviews/altrx) [Always Wellness and Recovery](https://thisglp.com/reviews/always-wellness-and-recovery) [AlyveRx](https://thisglp.com/reviews/alyverx) [AM Rx](https://thisglp.com/reviews/amrx) [Amazon One Medical](https://thisglp.com/reviews/amazon-one-medical) [Amble](https://thisglp.com/reviews/amble) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What does a month really cost? $248 for either oral at the entry dose and $398 for the Zepbound pen, because a $99 monthly membership sits on top of the medication figure. Are these compounded? No. Foundayo and Zepbound come through LillyDirect and the Wegovy Pill through NovoCare, all FDA-approved brand products. What happens as my dose rises? The manufacturer's ladder applies: Foundayo to $299 and the Zepbound pen to $449 at 7.5 mg and above, with the $99 membership unchanged throughout. Is PrideRx expensive compared with other GLP-1 telehealth sellers? PrideRx publishes a starting figure of $248/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts PrideRx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).